
EUDAMED Registration 2026
Missed the deadline: what really happens?
Who enforces the rules in all 27 EU Member States? Who can be held responsible? And what happens if a manufacturer registers only after 28 November 2026?
The EUDAMED deadline is not just an administrative date.
Once the transition period expires, certain medical devices and in vitro diagnostics already on the market can no longer continue to be newly placed on the EU market without the required EUDAMED product registration. The BfArM confirms this explicitly. The practical consequences depend on who breached which obligation and whether additional units were placed on the market after the deadline.
No automatic fine
A missing entry does not automatically generate a fine notice on 29 November.
Further placing on the market is risky
Placing new units on the market without the required registration may trigger sanctions.
Late registration is possible
It may restore compliance for future placements, but it does not automatically cure past violations.
What applies from 29 November 2026?
The first four EUDAMED modules have been mandatory since 28 May 2026. For certain products whose first units were placed on the market before that date, and for which additional units are still intended to be placed on the market, the transition period for UDI and product registration ends on 28 November 2026.
For products first placed on the market from 28 May 2026 onward, prior registration has generally been required since that date. Specific product categories and transition situations may be subject to exceptions and should be checked separately.
Under EU medical device law, “placing on the market” generally means the first making available of an individual unit on the EU market. Reselling units that were already lawfully placed on the market is not automatically a new placing on the market. A missing registration therefore does not automatically trigger a recall of all existing stock.
Registered too late: what happens in practice?
A late EUDAMED registration is not the same as a punishable further placing on the market. The three examples below illustrate the difference.
Registration on 5 December – no new units placed on the market beforehand
The manufacturer stops all further placing on the market of the affected products from 29 November and completes the registration afterwards.
Assessment: The registration was completed late. However, this situation alone does not constitute the offence of placing on the market without prior registration under Section 93 MPDG. Other obligations and possible measures must be assessed separately.
Further placing on the market on 1 December – registration only on 5 December
The manufacturer places additional units on the EU market despite the missing registration and only registers the products afterwards.
Assessment: The late registration does not retroactively cure the violation. Depending on the facts and the degree of fault, criminal, administrative-fine and market-surveillance action may follow.
Registration on 10 December – further placements only from 11 December
The manufacturer interrupts further placing on the market until the late registration has been completed and resumes it only afterwards.
Assessment: Once the registration has been completed and all other legal requirements are met, future placements on the market can generally resume.
Who checks – and how can a violation be detected?
Market surveillance is mainly carried out at national level. In practice, violations may become visible during inspections, document reviews, complaint-driven investigations, imports from third countries or cross-checks against EUDAMED.
Business inspection
Authorities may inspect manufacturers, importers or other economic operators and review whether product and actor obligations are being fulfilled.
Document review
Delivery records, product files and placing-on-the-market evidence can be checked against the timing of the EUDAMED registration.
Complaint-driven investigation
Complaints, incidents or suspicious discrepancies may trigger a focused review.
Unannounced control
National law may permit unannounced inspections or other supervisory action.
Which penalties and measures may apply?
There is no single EU-wide fine for missing EUDAMED registration. Member States define sanctions differently. Depending on the country and the legal basis, consequences may include administrative fines, criminal sanctions, cease-and-desist orders, restrictions on placing on the market, or other supervisory measures.
EUDAMED violations: what sanctions apply in the 27 EU Member States?
There is no harmonised EU fine. Member States define different offences, sanction ranges and competent authorities. This overview separates directly evidenced registration offences from general medical-device sanctions.
| EU country | Competent authority | Legal framework and assessment | Classification | National source |
|---|---|---|---|---|
| Belgium | FAMHP / FAGG | General criminal penalty levels; no isolated EUDAMED-specific amount confirmed.Belgian monetary penalties may increase through statutory multiplier factors; the Art. 29 linkage remains open. | General violation | Act of 22.12.2020, in particular Arts. 85–88 |
| Bulgaria | Bulgarian Drug Agency (BDA) | No reliably confirmed amount specifically for UDI/product registration.General national offences must be distinguished from EUDAMED-specific violations. | Not conclusively verified | Medical Devices Act – national implementation |
| Denmark | Danish Medicines Agency | A fine under national law is possible; no fixed amount for MDR Article 29 has been evidenced.The specific offence covered must be checked against the applicable national provision. | General violation | Medical Devices Act, §§ 20 et seq. |
| Germany | Landes-Marktüberwachungsbehörden; Strafverfolgungsbehörden | Intent: criminal fine or imprisonment of up to 1 year; negligence: administrative fine of up to €30,000.The punishable placing on the market without prior UDI registration must not be confused with merely missing the deadline. | Direct provision | Section 93(3) no. 1 and Section 94 MPDG |
| Estonia | Ravimiamet (State Agency of Medicines) | For certain unlawful placements on the market: fines; for legal entities, up to €32,000 under national law; Article 29 is not isolated.Fine levels and the exact offence should be confirmed against the current consolidated Estonian text. | General violation | Medical Devices Act, Section 39 |
| Finland | Fimea | A fine is possible for intentional or grossly negligent unlawful making available on the market; no statutory flat amount.Orders and coercive measures may also be relevant. | General violation | Act 719/2021, Section 57 |
| France | ANSM | For companies: up to 50% of the relevant French product turnover, capped at €5 million.The sanction targets placing on the market without the required product registration under MDR Article 29(4); it is not a blanket €5 million fine. | Direct provision | Articles L5461-9 no. 8 and L5471-1 Public Health Code |
| Greece | EOF (National Organization for Medicines) | No sufficiently evidenced amount for an isolated EUDAMED registration gap.Regulatory enforcement is possible; any quantified sanction requires a separate review of national law. | Not conclusively verified | National medical devices law / EOF |
| Ireland | HPRA; Strafverfolgung / Gerichte | Criminal sanctions are possible under the Medical Devices Regulations; the amount depends on the specific offence and procedure.No blanket maximum has been identified for a merely late UDI product registration. | General violation | S.I. 261/2021, Reg. 20/25; Irish Medicines Board Act, Section 32 |
| Italy | Ministero della Salute / zuständige Aufsicht | €8,150 to €48,500 for breaches of obligations under MDR Articles 29 and 31.The provision expressly names registration obligations of economic operators. | Direct provision | Article 27(12) Legislative Decree 137/2022 |
| Croatia | Ministerium für Gesundheit; HALMED | Fines exist under the national implementing act; the current euro amount for Article 29(4) is not verified.Older consolidated versions contain HRK penalty ranges and should not be published as current euro sanctions without further checking. | Not conclusively verified | Act implementing MDR/IVDR |
| Latvia | State Agency of Medicines (ZVA) | No isolated, verified fine amount for EUDAMED product registration.Additional national notification or registration duties may exist. | Not conclusively verified | Medical Devices Regulations (2023) |
| Lithuania | State Health Care Accreditation Agency (VASPVT) | General administrative fines for medical device violations; the Article 29 link is unconfirmed.There is no flat amount for an isolated late EUDAMED registration. | General violation | Administrative Offences Code, Article 59 |
| Luxembourg | Direction de la santé | No verified numeric penalty framework specifically for MDR Article 29.Supervision and measures are possible; the concrete fine requires a national legal analysis. | Not conclusively verified | National medical devices rules |
| Malta | Malta Medicines Authority | National criminal fines and imprisonment exist; no cleanly evidenced amount solely for a late EUDAMED registration.The high penalty ceilings in Maltese law should not be labelled as an EUDAMED fine without checking the exact offence. | General violation | Medical Devices Regulations (S.L. 458.59), Regulation 11 |
| Netherlands | IGJ; zuständiger Minister | Up to €110,000 for MDR Article 29(4) (5th fine category in 2026).The higher 6th category / 10% turnover applies to other separately listed offences, not to Article 29(4). | Direct provision | Article 14(2) Wet medische hulpmiddelen |
| Austria | BASG / AGES; Verwaltungsstrafbehörden | Up to €25,000, or €50,000 in the event of repeated violations, for covered MDR/IVDR offences.This depends on the concrete act and the applicable item of Section 80; it is not an automatic deadline fine. | General violation | Section 80 Medical Devices Act 2021 |
| Poland | URPL (Präsident des Amtes) | Up to PLN 200,000 for missing registration under MDR Articles 29(4) and 31(1).Separate offences exist for UDI assignment and the Basic UDI-DI. | Direct provision | Article 83(2) Medical Devices Act |
| Portugal | INFARMED | Serious registration offence: for companies, €1,700 to €24,000 depending on size.Different thresholds apply to natural persons and negligence; product registration and actor registration must be distinguished. | Direct provision | Article 44(2)(v)/(w) Decree-Law 29/2024; Decree-Law 9/2021 |
| Romania | ANMDMR | National administrative fines exist for certain MDR obligations; no specific amount for Article 29(4) has been confirmed.Different paragraphs cover individual Article 29 obligations and economic-operator duties separately. | General violation | Emergency Ordinance 46/2021, Articles 28–29 |
| Sweden | Läkemedelsverket | A criminal fine or imprisonment of up to 1 year may apply to certain intentional or negligent unlawful placements on the market.This is a general market offence, not an automatically punishable missing data entry. | General violation | Chapter 5, Section 1, Act 2021:600 |
| Slovakia | ŠÚKL | €5,000 to €100,000 for certain missing product registrations prior to placing on the market.New legal version applies from 01.11.2026; corresponding IVDR rules must also be considered. | Direct provision | Section 138b(5)(a), (8) version effective 01.11.2026 |
| Slovenia | JAZMP | For serious unlawful placing on the market: €8,000 to €120,000 for legal entities.This is a general violation of MDR/IVDR Article 5; a missing Article 29 registration should not automatically be equated with the maximum amount. | General violation | Section 37(1) no. 6 ZMedPri-1 (2025) |
| Spain | AEMPS; Gesundheitsbehörden der autonomen Gemeinschaften | General medical-device sanction framework up to €30,000 / €90,000 / €1 million depending on the category of infringement.The allocation of an isolated EUDAMED registration gap to a specific category is not confirmed. | General violation | Royal Legislative Decree 1/2015, Articles 112 and 114 |
| Czech Republic | SÚKL | Up to CZK 15 million for certain UDI and product-registration violations; separate duties exist for economic operators.The exact subparagraph and the affected obligation must be checked case by case. | Direct provision | Section 55 Act No. 375/2022 |
| Hungary | NNGYK | No verified EUDAMED-specific fine amount was found in the reviewed official sources.Regulatory measures and other national sanctions remain possible. | Not conclusively verified | National MDR implementation / NNGYK |
| Cyprus | Gesundheitsministerium – Medical Devices Competent Authority | No verified current amount for isolated UDI or product-registration violations.Amounts from draft laws should not be published as current law. | Not conclusively verified | National MDR implementation; competent authority |
Who can be responsible?
Manufacturer
Product registration
The manufacturer is generally responsible for registering the relevant products in EUDAMED and ensuring that the required product data are complete and correct.
Importer
Own compliance obligations
Importers have their own duties as economic operators and must not place non-compliant products on the market once a relevant non-compliance is known or suspected.
Authorised Representative
Mandate and own obligations
The authorised representative has its own legal obligations, but it does not automatically become the party directly liable for every missed product registration by the manufacturer.
Distributor
Due care when making available
Distributors usually do not perform product registration themselves, but they still have due-diligence duties and may be affected by supervisory action if non-compliant products are made available.
Why waiting can become expensive – even without an immediate fine
Even where no authority acts on the first day after the deadline, manufacturers may face delayed shipments, interrupted placing on the market, increased workload for data clean-up, tension with importers and distributors, and potential contractual consequences. The longer registration gaps remain open, the longer the business risk continues.
What should companies do if registrations are still missing?
- Identify which products are actually subject to the registration obligation.
- Separate products already lawfully on the market from units that are still to be newly placed on the market.
- Review UDI and product data for completeness and consistency.
- Complete missing registrations as quickly as possible.
- Pause further placing on the market of affected products until compliance is restored.
- Document the timeline and the corrective actions taken.
Structured data transfer
Large UDI data sets? Turn registration into a structured process.
For companies with many products and variants, manual entry is often slow and error-prone. XML bulk upload and machine-to-machine processes can reduce manual workload and make large product portfolios easier to manage.
Frequently asked questions
Will a fine be imposed automatically on 29 November 2026?
No. A missing registration does not automatically trigger a fine notice the next day. The legal consequences depend on the specific conduct and the applicable national rules.
Can products still be registered after the deadline?
Yes. Late registration is possible. However, it does not automatically erase violations that may already have occurred in the meantime.
Can a manufacturer wait until an authority checks the case?
That is a business and legal risk. The fact that a violation is not immediately detected does not make further placing on the market lawful.
Does a late registration automatically require a recall?
No. The legal assessment depends on whether individual units were already lawfully placed on the market and on what happened after the deadline.
Official legal sources
- BfArM – EUDAMED registration FAQ
- European Commission – Getting ready for mandatory EUDAMED use
- Regulation (EU) 2017/745 (MDR)
- Regulation (EU) 2017/746 (IVDR)
Note: This article provides general regulatory information and does not replace legal advice. National sanction rules differ significantly across the EU and should be reviewed for the concrete fact pattern.









Related Posts